Eucommia ulmoides male flower roxburgh rose oral liquid and application thereof

Abstract

The invention discloses eucommia ulmoides male flower roxburgh rose oral liquid and application thereof. The eucommia ulmoides male flower roxburgh rose oral liquid is prepared from the following medicinal materials: 1-1.5 parts of eucommia male flowers, 0.7-1 part of rhizoma polygonati, 0.7-1 part of radix puerariae, 1-1.2 parts of seville orange flowers, 0.8-1.2 parts of radix polygonati officinalis, 0.8-1 part of herba cepbalanoplosis segeti, 0.9-1.2 parts of semen brassicae, 1-1.1 parts of honeysuckle flowers, 1.2-1.5 parts of dandelions, 1-1.2 parts of herba portulacae, 0.8-1.2 parts of semen torreya, 0.9-1.3 parts of rhizoma galangae, 0.7-0.9 part of a seaweed extract, 0.8-1 part of a roxburgh rose extract and 0.7-1.4 parts of a blueberry extract. The herba portulacae, the seville orange flower, the blueberry extract, the honeysuckle flower and the dandelion are matched and reasonably proportioned, the components have a synergistic interaction function and can act on cancer cells by strengthening body resistance, clearing away heat and toxic materials and the like, so that growth and deterioration of early cancer cells are effectively controlled, and side effects of radiotherapy and chemotherapy can be reduced; eucommia male flowers and seaweed extracts can improve sleep of patients and repair immune functions.

Description

technical field [0001] The invention relates to the technical field of anticancer drugs, in particular to an oral liquid of Eucommia ulmoides Xionghua roxburghii and an application thereof. Background technique [0002] Cancer is the great enemy of human health, but so far there is no effective treatment, which belongs to one of the unconquered fortresses in the medical field. Currently, the treatment methods for cancer are mainly surgical treatment, chemotherapy and radiotherapy of western medicine. However, while radiotherapy and chemotherapy kill tumor cells, they also kill normal cells and immune cells, resulting in impaired immune function and low immunity in patients, causing great damage to the patient's body. [0003] At present, most of the drugs for the treatment of advanced malignant tumors have a considerable degree of toxic and side effects, and the therapeutic effect is not very satisfactory, and tumor patients often have obvious reaction symptoms after taking...

AI Technical Summary

Problems solved by technology

However, while radiotherapy and chemotherapy kill tumor cells, they also kill normal cells and immune cells, resulting in impaired immune function and low immunity in patients, causing great damage to the patient's body

[0003] At present, most of the drugs for the treatment of advanced malignant tumors have a considerable degree of toxic and side effects, and the therapeutic effect is not very satisfactory. After taking it, tumor patients often have obvious reaction symptoms.